GlassScriptPhysician profile
Matthew Delfino Lyons
NPI 1962840181
$6,557.49
in general payments reported to CMS, 2019-2025
29 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $830 · 2021: $530 · 2022: $2,752 · 2023: $669 · 2024: $552 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,920.20 | 2022-2023 | Da Vinci Surgical System |
| Teleflex LLC | $770.26 | 2020-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $731.85 | 2019-2024 | Lumenis Pulse 50h |
| Astellas Pharma US INC | $396.52 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $311.39 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $311.10 | 2019-2024 | Erleada |
| Endo Pharmaceuticals INC. | $275.26 | 2019-2024 | Xiaflex |
| Antares Pharma, INC. | $200.56 | 2019-2022 | |
| Procept Biorobotics Corporation | $175.96 | 2024-2025 | Aquabeam System |
| Urovant Sciences INC | $162.06 | 2021-2022 | |
| Medtronic, INC. | $157.09 | 2023-2025 | Altaviva, Interstim |
| Neotract INC. | $156.75 | 2020 | |
| Urogen Pharma, INC. | $141.29 | 2022-2024 | |
| Myriad Genetic Laboratories, INC. | $130.94 | 2020-2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $107.62 | 2019 | |
| Calyxo, INC. | $107.07 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $48.45 | 2019-2021 | |
| Ambu INC. | $46.58 | 2024 | |
| Smith+Nephew, INC. | $44.67 | 2025 | Stravix |
| Endo USA, INC. | $40.78 | 2025 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $36.72 | 2019-2021 | |
| Coloplast Corp | $32.97 | 2023 | Speedicath |
| Zyla Life Sciences, INC. | $29.49 | 2019-2020 | |
| Pfizer INC. | $24.44 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $23.83 | 2025 | |
| Becton, Dickinson and Company | $22.55 | 2025 | Hemosphere |
| Photocure INC | $16.80 | 2022 | |
| Allergan, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.